AAAP Addiction Psychotherapy: Treating Addiction & Co-Occurring Conditions

Expert-Led. Clinically Relevant. Free.

Addiction rarely occurs in isolation. Effective treatment often requires clinicians to address substance use alongside co-occurring psychiatric, behavioral, and medical conditions—and to draw from a range of evidence-based psychotherapeutic approaches.

AAAP Addiction Psychotherapy: Treating Addiction & Co-Occurring Conditions connects addiction professionals with leading experts in psychotherapy, addiction psychiatry, and behavioral health to explore practical strategies for treating substance use disorders and the complex conditions that frequently accompany them.

With 10 live webinars each year and a growing library of on-demand sessions, this free series makes high-quality addiction psychotherapy education accessible throughout the year.

Explore evidence-based and emerging psychotherapeutic approaches used in addiction care, including:

CBT • DBT • ACT • Motivational Interviewing • Contingency Management • 12-Step Facilitation • SMART Recovery • Trauma-Focused Therapies • EMDR • Internal Family Systems • Seeking Safety • Mindfulness • Group Psychotherapy—and more.

Sessions also address the co-occurring conditions and clinical challenges that can shape addiction treatment, including:

Trauma • PTSD • Borderline Personality Disorder • ADHD • Insomnia • Chronic Pain • Suicidality • Personality Disorders • Recovery and Relapse—and more.

The result is education that goes beyond a single diagnosis or therapeutic technique to help clinicians navigate the complex realities of treating addiction and co-occurring conditions.

Learn From Leaders in Addiction and Psychotherapy

Hear directly from nationally and internationally recognized clinicians, researchers, and psychotherapy experts—including individuals who have developed, studied, and advanced many of the approaches featured in the series.

Past and current faculty include Stephen Hayes, PhD; Keith Humphreys, OBE, PhD; Donna Sudak, MD; Richard Rawson, PhD; Shelly Greenfield, MD; Lisa Najavits, PhD; David Jobes, PhD, ABPP; Eric Garland, PhD, LCSW; Theresa Moyers, PhD; Richard Schwartz, PhD; Lois Choi-Kain, MD, MEd; and many others.

Join Live—or Learn On Your Schedule

Participate in upcoming live webinars throughout the year or explore the growing collection of on-demand sessions whenever it works for you.

Whether you want to strengthen core psychotherapy skills, expand your approach to addiction treatment, or better address the psychiatric, behavioral, and medical conditions that commonly co-occur with substance use disorders, the series offers practical education you can put to work with patients.

10 live webinars each year. A growing on-demand library. Leading experts in addiction and psychotherapy. All FREE.

These sessions, developed by the American Academy of Addiction Psychiatry (AAAP) in collaboration with Oregon Health and Science University (OHSU) and NYU School of Medicine, are a great way to keep up to date with best practices in patient management.

Register for upcoming webinars here: https://www.aaap.org/education/upcoming-webinars/
Access the library: https://education.aaap.org/URL/Catalog2026

Better Psychotherapy. More Comprehensive Addiction Care.

After participating in the sessions, learners will be able to:

Implement psychotherapeutic interventions in clinical practice
Choose appropriate psychotherapeutic modality for referral
Incorporate psychotherapeutic interventions into training and supervision

Christopher Blazes, M.D.; Assistant Professor of Psychiatry, Oregon Health and Science University. Dr. Blazes is triple board-certified in psychiatry, addiction psychiatry, and emergency medicine and is the director of the OHSU addiction psychiatry Fellowship. He is a clinician educator whose practice is based out of the Portland VA Medical Center. He lectures widely and publishes on such topics as benzodiazepines, synthetic fentanyl analogues, buprenorphine, and the neurobiology of addiction and recovery. He is currently the principal investigator for a trial studying buprenorphine inductions on patients using fentanyl. He also recently published an article in JAMA Psychiatry describing a new clinical entity, Complex Persistent Benzodiazepine Dependence as well as an article “Reconsidering the usefulness of adding naloxone to buprenorphine”.

Jon (David) Stiffler, M.D.; Associate Professor of Psychiatry at NYU. Dr. Stiffler graduated with a Bachelor of Science in biochemistry and molecular biology from The Pennsylvania State University and received his M.D. from The Pennsylvania State University College of Medicine in 2010. After completing residency training at New York University where he was chief resident, he went on to complete a fellowship in Addiction Psychiatry at New York University. Dr. Stiffler is currently a Clinical Associate Professor of Psychiatry and the Associate Program Director of the Addiction Psychiatry Fellowship Training Program in The University of California, San Diego Department of Psychiatry. He remains an Adjunct Assistant Professor at the New York University Department of Psychiatry. He is board certified in General Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology.

ASAM/AAAP Management of Stimulant Use Disorder Webinar Series #4: Medication Management for Stimulant Use Disorder

Multiple Credits

Free

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events